von Willebrand factor antigen, von Willebrand factor propeptide and ADAMTS13 activity in TIA or ischaemic stroke patients changing antiplatelet therapy von Smith, D.R., Lim, S.T., Murphy, S.J.X., Hickey, F.B., Offiah, C., Murphy, S.M., Collins, D.R., Coughlan, T., O'Neill, D., Egan, B., O'Donnell, J.S., O'Sullivan, J.M., McCabe, D.J.H.

Volltext

Assessment of on-treatment platelet reactivity at high and low shear stress and platelet activation status after the addition of dipyridamole to aspirin in the early and late phase... von Lim, S.T., Murphy, S.J.X., Murphy, S.M., Coughlan, T., O'Neill, D., Tierney, S., Egan, B., Collins, D.R., McCarthy, A.J., Lim, S.-Y., Smith, D.R., Cox, D., McCabe, D.J.H.

Volltext

Optimal Antiplatelet Therapy in Moderate to Severe Asymptomatic and Symptomatic Carotid Stenosis: A Comprehensive Review of the Literature von Murphy, S.J.X., Naylor, A.R., Ricco, J.-B., Sillesen, H., Kakkos, S., Halliday, A., de Borst, G.J., Vega de Ceniga, M., Hamilton, G., McCabe, D.J.H.

Volltext